Clinical and molecular aspects of an informative family with neurofibromatosis type 1 and Noonan phenotype
- PMID: 16542390
- PMCID: PMC3243644
- DOI: 10.1111/j.1399-0004.2006.00576.x
Clinical and molecular aspects of an informative family with neurofibromatosis type 1 and Noonan phenotype
Abstract
Neurofibromatosis-Noonan syndrome (NFNS) has been described as a unique phenotype, combining manifestations of neurofibromatosis type 1 (NF1) and Noonan syndrome, which are separate syndromes. Potential etiologies of NFNS include a discrete syndrome of distinct etiology, co-segregation of two mutated common genes, variable clinical expressivity of NF1, and/or allelic heterogeneity. We present an informative family with an unusual NF1 mutation with variable features of NF1 and Noonan syndrome. We hypothesize that an NF1 mutant allele can lead to diagnostic manifestations of Noonan syndrome, supporting the hypothesis that NF1 allelic heterogeneity causes NFNS.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3243644/bin/nihms343311f1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3243644/bin/nihms343311f2.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3243644/bin/nihms343311f3.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3243644/bin/nihms343311f4.gif)
![Figure 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3243644/bin/nihms343311f5.gif)
Similar articles
-
Novel association of neurofibromatosis type 1-causing mutations in families with neurofibromatosis-Noonan syndrome.Am J Med Genet A. 2014 Mar;164A(3):579-87. doi: 10.1002/ajmg.a.36313. Epub 2013 Dec 19. Am J Med Genet A. 2014. PMID: 24357598
-
A variable combination of features of Noonan syndrome and neurofibromatosis type I are caused by mutations in the NF1 gene.Am J Med Genet A. 2006 Dec 15;140(24):2749-56. doi: 10.1002/ajmg.a.31547. Am J Med Genet A. 2006. PMID: 17103458
-
Noonan-like/multiple giant cell lesion syndrome: report of a case and review of the literature.J Oral Maxillofac Surg. 2006 Aug;64(8):1289-92. doi: 10.1016/j.joms.2006.04.025. J Oral Maxillofac Surg. 2006. PMID: 16860226 Review. No abstract available.
-
Different mutations in the NF1 gene are associated with Neurofibromatosis-Noonan syndrome (NFNS).Am J Med Genet A. 2003 May 15;119A(1):1-8. doi: 10.1002/ajmg.a.20023. Am J Med Genet A. 2003. PMID: 12707950
-
Genetics of neurofibromatosis 1 and the NF1 gene.J Child Neurol. 2002 Aug;17(8):562-70; discussion 571-2, 646-51. doi: 10.1177/088307380201700804. J Child Neurol. 2002. PMID: 12403554 Review.
Cited by
-
Mutation analysis and clinical profile of South African patients with Neurofibromatosis type 1 (NF1) phenotype.Front Genet. 2024 Mar 26;15:1331278. doi: 10.3389/fgene.2024.1331278. eCollection 2024. Front Genet. 2024. PMID: 38596211 Free PMC article.
-
Neurofibromatosis-Noonan syndrome and growth deficiency in an Iranian girl due to a pathogenic variant in NF1 gene.Hum Genomics. 2023 Feb 20;17(1):12. doi: 10.1186/s40246-023-00460-0. Hum Genomics. 2023. PMID: 36803953 Free PMC article.
-
LZTR1 molecular genetic overlap with clinical implications for Noonan syndrome and schwannomatosis.BMC Med Genomics. 2022 Jul 15;15(1):160. doi: 10.1186/s12920-022-01304-x. BMC Med Genomics. 2022. PMID: 35840934 Free PMC article. Review.
-
A Novel Heterozygous NF1 Variant in a Neurofibromatosis-Noonan Syndrome Patient with Growth Hormone Deficiency: A Case Report.J Clin Res Pediatr Endocrinol. 2023 Nov 22;15(4):438-443. doi: 10.4274/jcrpe.galenos.2022.2021-12-24. Epub 2022 May 31. J Clin Res Pediatr Endocrinol. 2023. PMID: 35633639 Free PMC article.
-
Juvenile xanthogranuloma in Noonan syndrome.Am J Med Genet A. 2021 Oct;185(10):3048-3052. doi: 10.1002/ajmg.a.62353. Epub 2021 May 25. Am J Med Genet A. 2021. PMID: 34032360 Free PMC article.
References
-
- Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, Rubenstein A, Viskochil D. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA. 1997;278:51–57. - PubMed
-
- Stumpf DA, Alksne JF, Annegers JF, Brown SS, Conneally PM, Housman D, Leppert MF, Miller JP, Moss ML, Pileggi AJ, Rapin I, Strohman RC, Swanson LW, Zimmerman A. Neurofibromatosis conference statement national institutes of health consensus development conference. Arch Neurol. 1988;45:575–578. - PubMed
-
- Carey J, Baty B, Johnson J, Morrison T, Skolnick M, Kivlin J. The genetic aspects of neurofibromatosis. Ann NY Acad Sci. 1986;486:45–52. - PubMed
-
- Viskochil D. Genetics of neurofibromatosis 1 and the NF1 gene. J Child Neurol. 2002;17:562–570. - PubMed
-
- Nora JJ, Nora AH, Sinha Ak, Spangler RD, Lubs HA. The Ullrich-Noonan syndrome (Turner phenotype) Am J Dis Child. 1974;127:48–55. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous